Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway (Q71400868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

author name string

D M Hilbert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

T S Migone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

W J Leonard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

S Rudikoff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

publication date

1 July 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

81-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

18 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Induction of Plasma Cell Tumours in BALB/c Mice with 2,6,10,14-Tetramethylpentadecane (Pristane)

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11. Identification as a stroma-derived activin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Jak-STAT signaling induced by the v-abl oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

In vitro culture of primary plasmacytomas requires stromal cell feeder layers

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Oncogenic activation of c-ABL by mutation within its last exon.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Molecular cloning and expression of an IL-6 signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Interleukin 6 is essential for in vivo development of B lineage neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Coupling protein design and in vitro selection strategies: improving specificity and affinity of a designed beta-protein IL-6 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Induction of plasma-cell neoplasms and fibrosarcomas in BALB/c mice carrying diffusion chambers

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Serine- and threonine-specific protein kinase activities of purified gag-mil and gag-raf proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Signal transduction through IL-6 receptor: involvement of multiple protein kinases, stat factors, and a novel H7-sensitive pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

In vitro expansion of the murine pluripotent hemopoietic stem cell population in response to interleukin 3 and interleukin 6. Application to bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Interferon-gamma in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil Adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

The role of interleukin-6 in mucosal IgA antibody responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

v-abl does not abolish IL-6 requirement by murine plasmacytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

An altered v-raf is required in addition to v-myc in J3V1 virus for acceleration of murine plasmacytomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980312-X

7 January 2021

10.1016/S1074-7613(00)80312-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8758897%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference